Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients

Clinical trial NCT00509938 · COMPLETED

Trial details

NCT number: NCT00509938
Sponsor: AM-Pharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematopoietic Stem Cell Transplantation Bacterial Infections and Mycoses

Start date: 2006-03-01
Primary completion: 2006-11-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.